Medicolegal Issues

Pharmacologic performance enhancement: What to consider before prescribing

Author and Disclosure Information

 

References

What to do if you decide to prescribe

Inevitably, the decision to prescribe psychotropic medications for performance enhancement is a physician-specific one. Certainly, psychiatrists should not feel obligated to prescribe performance enhancers. Given our current state of pharmacology, it is unclear whether medications would be helpful in the absence of psychopathology. When deciding whether to prescribe for performance enhancement in the absence of psychopathology, we suggest first carefully considering how to maintain the ethical value of nonmaleficence by weighing both the potential physical and psychologic harms of prescribing as well as the legal risks and rules of applicable sport governing bodies.

For a psychiatrist who chooses to prescribe for performance enhancement, we recommend conducting a thorough psychiatric assessment to determine whether the patient has a treatable mental illness. If so, then effective treatment of that illness should take priority. Before prescribing, the psychiatrist and patient should discuss the patient’s specific performance goals and how to measure them.

Any prescription for a performance-enhancing medication should be given in conjunction with nonpharmacologic approaches, including optimizing diet, exercise, and sleep. Therapy to address problem-solving techniques and skills to cope with stress may also be appropriate. The patient and psychiatrist should engage in regular follow-up to assess the efficacy of the medication, as well as its safety and tolerability. Finally, if a medication is not efficacious as a performance enhancer, then both the patient and psychiatrist should be open to re-evaluating the treatment plan, and when appropriate, stopping the medication.

Pages

Recommended Reading

The election’s impact on health care: Some bellwether races to watch
MDedge Psychiatry
CMS delays controversial E/M changes in final rule
MDedge Psychiatry
Open enrollment: Slow first week at HealthCare.gov
MDedge Psychiatry
Midterm election boosts Medicaid expansion, but challenges remain
MDedge Psychiatry
Open enrollment: HealthCare.gov busier in week 2
MDedge Psychiatry
Part D proposal includes prior authorization, step therapy
MDedge Psychiatry
Democrats taking key leadership jobs have pocketed millions from Pharma
MDedge Psychiatry
Under Trump, number of uninsured kids rose for first time this decade
MDedge Psychiatry
Open enrollment: Weekly volume down again
MDedge Psychiatry
Feds call for EHR interoperability. Again.
MDedge Psychiatry